NVS peer analysis
Novartis (NVS) against its competitors: price, today's move, 1-year return and market value side by side.
- NVS's peers: ABBV (AbbVie), AZN (AstraZeneca), BMY (Bristol-Myers Squibb), GILD (Gilead), GSK (GSK), JNJ (Johnson & Johnson), MRK (Merck), NVO (Novo Nordisk).
NVS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $286.20 | 0.94% | 22.88% | $505.89B |
| AZN AstraZeneca | $174.30 | -0.63% | -2.07% | $270.32B |
| BMY Bristol-Myers Squibb | $59.00 | 1.13% | 28.85% | $120.60B |
| GILD Gilead | $167.58 | 0.63% | 30.85% | $207.86B |
| GSK GSK | $47.96 | 0.28% | 3.49% | $96.12B |
| JNJ Johnson & Johnson | $270.47 | 1.25% | 33.56% | $651.11B |
| MRK Merck | $133.72 | 0.69% | 40.68% | $329.65B |
| NVO Novo Nordisk | $37.82 | -2.70% | -22.82% | $167.31B |
| PFE Pfizer | $27.44 | -0.36% | 10.29% | $156.40B |
| SNY Sanofi | $46.52 | 1.00% | -6.12% | $111.70B |
| NVS Novartis | $150.00 | -0.81% | 17.82% | $283.29B |